Vieworks Co., Ltd. (KOSDAQ:100120)
21,700
-150 (-0.69%)
Jun 27, 2025, 3:30 PM KST
Vieworks Revenue
Vieworks had revenue of 54.40B KRW in the quarter ending March 31, 2025, a decrease of -10.16%. This brings the company's revenue in the last twelve months to 216.75B, down -4.08% year-over-year. In the year 2024, Vieworks had annual revenue of 222.90B with 1.20% growth.
Revenue (ttm)
216.75B
Revenue Growth
-4.08%
P/S Ratio
0.90
Revenue / Employee
445.06M
Employees
487
Market Cap
195.13B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 222.90B | 2.65B | 1.20% |
Dec 31, 2023 | 220.25B | -17.68B | -7.43% |
Dec 31, 2022 | 237.93B | 44.79B | 23.19% |
Dec 31, 2021 | 193.14B | 32.88B | 20.51% |
Dec 31, 2020 | 160.26B | 24.25B | 17.83% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |